Skip to content

A clinical study using gender identity questionnaire and fMRI to construct gender determination for PAIS children

A clinical study using gender identity questionnaire and fMRI to construct gender determination for PAIS children

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036705
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Partial androgen insensitivity syndrome

Interventions

PAIS group:Nil
normal control group:Nil

Sponsors

Shanghai Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 10 Years

Inclusion criteria

Inclusion criteria: (1) Aged < 10 years; (2) The gender phenotype of external genitalia is unclear; (3) Sex hormone detection androgen increased or normal, pituitary secretion of FSH, LH function is normal; (4) There were testis in pelvic imaging examination, but the uterus was not detected; (5) Karyotype analysis was consistent with 46, XY; (6) Clinical gene detection of AR gene abnormalities; (7) Exclude 5- reductase 2 deficiency, adrenocortical hyperplasia and other diseases.

Exclusion criteria

Exclusion criteria: (1) Combined with other genetic or clinical phenotypic defects; (2) A history of brain injury with mental retardation; (3) Very low birth weight infant; (4) MRI monitoring was contraindicated; (5) The informed consent of the guardian cannot be obtained.

Design outcomes

Primary

MeasureTime frame
The size of the amygdala;questionnaire score;

Countries

China

Contacts

Public ContactYan Li

Shanghai Children's Hospital

liyan880101@163.com+86 18016493502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026